SG11201401739YA - Methods of reducing or eliminating protein modification and degradation arising from exposure to uv light - Google Patents

Methods of reducing or eliminating protein modification and degradation arising from exposure to uv light

Info

Publication number
SG11201401739YA
SG11201401739YA SG11201401739YA SG11201401739YA SG11201401739YA SG 11201401739Y A SG11201401739Y A SG 11201401739YA SG 11201401739Y A SG11201401739Y A SG 11201401739YA SG 11201401739Y A SG11201401739Y A SG 11201401739YA SG 11201401739Y A SG11201401739Y A SG 11201401739YA
Authority
SG
Singapore
Prior art keywords
exposure
reducing
methods
light
protein modification
Prior art date
Application number
SG11201401739YA
Inventor
Joseph Edward Shultz
Roger Hart
Brent Welborn
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of SG11201401739YA publication Critical patent/SG11201401739YA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/10Ultra-violet radiation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/24Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the treatment of the fractions to be distributed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
SG11201401739YA 2011-10-26 2012-10-25 Methods of reducing or eliminating protein modification and degradation arising from exposure to uv light SG11201401739YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161551822P 2011-10-26 2011-10-26
PCT/US2012/061965 WO2013063298A1 (en) 2011-10-26 2012-10-25 Methods of reducing or eliminating protein modification and degradation arising from exposure to uv light

Publications (1)

Publication Number Publication Date
SG11201401739YA true SG11201401739YA (en) 2014-05-29

Family

ID=47138200

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401739YA SG11201401739YA (en) 2011-10-26 2012-10-25 Methods of reducing or eliminating protein modification and degradation arising from exposure to uv light

Country Status (16)

Country Link
US (1) US10634589B2 (en)
EP (1) EP2771038B1 (en)
JP (2) JP6526414B2 (en)
KR (1) KR102091294B1 (en)
CN (1) CN104136047B (en)
AU (1) AU2012328753A1 (en)
BR (1) BR112014010027A2 (en)
CA (1) CA2853371A1 (en)
EA (2) EA034347B1 (en)
ES (1) ES2693508T3 (en)
HK (1) HK1203423A1 (en)
IL (1) IL232019A0 (en)
MX (1) MX361039B (en)
SG (1) SG11201401739YA (en)
WO (1) WO2013063298A1 (en)
ZA (1) ZA201402923B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9603956B2 (en) * 2013-12-12 2017-03-28 Paul Newham Dynamic enhanced and diffuse broad spectrum UVC or alternative controlled ionizing radiation source emitters for mobile and fixed placement disinfection of clinical surfaces
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
PT3152317T (en) 2014-06-04 2019-04-18 Amgen Inc Methods for harvesting mammalian cell cultures
SG11201704351WA (en) 2014-12-01 2017-06-29 Amgen Inc Process for manipulating the level of glycan content of a glycoprotein
WO2018083248A1 (en) 2016-11-03 2018-05-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
CN107496950B (en) * 2017-08-18 2021-02-02 广州市众为生物技术有限公司 Method for inactivating virus in protein solution by ultraviolet irradiation
US20230256130A1 (en) 2020-07-27 2023-08-17 Riken Infection prevention device and infection prevention method
EP4189064A1 (en) 2020-07-30 2023-06-07 Amgen Inc. Cell culture media and methods of making and using the same

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981163A (en) * 1990-05-15 1999-11-09 New York Blood Center, Inc. Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (en) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd Humanized b-b10
JP3426237B2 (en) * 1993-05-28 2003-07-14 ニューヨーク ブラッド センター,インコーポレイティド Method for sterilizing biological compositions and formulations produced by this method
JPH0758031A (en) 1993-08-18 1995-03-03 Nissin Electric Co Ltd Ion deposition thin film forming apparatus and film forming method using the same
US5925885A (en) * 1996-05-22 1999-07-20 Purepulse Technologies, Inc. Parametric control in pulsed light sterilization of packages and their contents
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
JPH11286453A (en) * 1998-03-31 1999-10-19 Yoshitomi Pharmaceut Ind Ltd Virus inactivation treatment of protein-containing composition by irradiation of ultraviolet light
GB9821342D0 (en) 1998-10-02 1998-11-25 Common Services Agency Device for treatment of biological fluids
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
EP1229852A4 (en) * 1999-10-08 2006-03-15 Britesmile Inc Apparatus for simultaneous illumination of teeth
GB9928787D0 (en) 1999-12-03 2000-02-02 Medical Res Council Direct screening method
CA2403834A1 (en) * 2000-03-23 2001-09-27 Clearant, Inc. Methods for sterilizing biological materials
GB0025144D0 (en) 2000-10-13 2000-11-29 Medical Res Council Concatenated nucleic acid sequences
US6682695B2 (en) * 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
JP2004533318A (en) 2001-05-17 2004-11-04 ピュアパルス テクノロジーズ インコーポレイテッド Method and apparatus for a system for processing fluid products using light
US20030064001A1 (en) 2001-05-17 2003-04-03 Fries William M. System for the decontamination of fluid products using light
JP2004520448A (en) * 2001-05-30 2004-07-08 ガンブロ、 インコーポレイテッド Virus inactivation method using antioxidants
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
GB0117571D0 (en) * 2001-07-19 2001-09-12 Common Services Agency UV irradiation control
US20030064000A1 (en) * 2001-09-24 2003-04-03 Wilson Burgess Methods of sterilizing biological mixtures using stabilizer mixtures
US20030059338A1 (en) 2001-09-24 2003-03-27 Mann David M. Methods for sterilizing biological materials using flavonoid/flavonol stabilizers
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US20060234226A1 (en) * 2002-04-26 2006-10-19 Fahner Robert L Non-affinity purification of proteins
EP1415669A1 (en) * 2002-09-19 2004-05-06 Aventis Behring GmbH Process for sterilization of protein containing biological compositions
AR042545A1 (en) 2002-12-20 2005-06-22 Amgen Inc BINDING AGENTS THAT INHIBIT MIOSTATINE
US20040202995A1 (en) 2003-04-09 2004-10-14 Domantis Nucleic acids, proteins, and screening methods
US20050264236A1 (en) 2004-05-25 2005-12-01 Purepulse Technologies, Inc Apparatus and method for use in triggering a flash lamp
US7993580B2 (en) * 2004-08-24 2011-08-09 Baxter International Inc. Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors
US20070009377A1 (en) 2005-07-06 2007-01-11 Navigant Biotechnologies, Inc. Methods for Reducing Pathogens in Biological Samples
US7998717B2 (en) 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
WO2007075283A2 (en) 2005-12-06 2007-07-05 Amgen Inc. Polishing steps used in multi-step protein purification processes
BRPI0809112A2 (en) * 2007-03-22 2014-08-26 Imclone Llc STABLE ANTIBODY FORMULATIONS
CA2690673C (en) * 2007-06-15 2013-04-23 Amgen Inc. Methods of treating cell culture media for use in a bioreactor
US8547536B2 (en) * 2007-12-10 2013-10-01 Novartis Ag Analysis of mixtures including proteins
US7585679B1 (en) * 2008-02-22 2009-09-08 Dionex Corporation Ion chromatography system with flow-delay eluent recycle
WO2009106629A1 (en) * 2008-02-29 2009-09-03 Universiteit Gent Viral inactivation process
EP3960854A1 (en) * 2008-03-06 2022-03-02 Halozyme, Inc. Large-scale production of soluble hyaluronidase
EP2684570A1 (en) * 2008-09-10 2014-01-15 F. Hoffmann-La Roche AG Compositions and methods for the prevention of oxidative degradation of proteins
EP2451527B1 (en) 2009-07-09 2018-11-21 Koninklijke Philips N.V. Skin radiation apparatus

Also Published As

Publication number Publication date
EA201490867A1 (en) 2014-12-30
JP6526414B2 (en) 2019-06-05
KR20140079829A (en) 2014-06-27
ZA201402923B (en) 2015-04-29
EA201992617A1 (en) 2020-03-10
EA034347B1 (en) 2020-01-30
BR112014010027A2 (en) 2017-04-25
HK1203423B (en) 2018-08-17
JP2017061462A (en) 2017-03-30
CA2853371A1 (en) 2013-05-02
WO2013063298A1 (en) 2013-05-02
JP2014533942A (en) 2014-12-18
EP2771038A1 (en) 2014-09-03
CN104136047A (en) 2014-11-05
US20140329227A1 (en) 2014-11-06
JP6539246B2 (en) 2019-07-03
EP2771038B1 (en) 2018-10-10
KR102091294B1 (en) 2020-04-16
IL232019A0 (en) 2014-05-28
AU2012328753A1 (en) 2014-04-24
ES2693508T3 (en) 2018-12-12
CN104136047B (en) 2018-02-06
HK1203423A1 (en) 2015-10-30
US10634589B2 (en) 2020-04-28
MX361039B (en) 2018-11-26
MX2014004880A (en) 2014-09-15

Similar Documents

Publication Publication Date Title
HK1203423A1 (en) Methods of reducing or eliminating protein modification and degradation arising from exposure to uv light uv
ZA201503332B (en) Water treatment composition and method of using same
HK1258530A1 (en) Serpina 1 sirnas: compositions of matter and methods of treatment
PT2776567T (en) Compositions and methods for treatment of cytomegalovirus
EP2771030A4 (en) Compositions and methods for treatment of proteinopathies
EP2841121A4 (en) Method and system for therapeutic use of ultra-violet light
GB201106960D0 (en) Treatment of waste
HK1199015A1 (en) Treatment of inflammation
EP2773212A4 (en) Methods and compositions for treatment of autism
HK1201439A1 (en) Method of treating or reducing efp efp
EP2755668A4 (en) Hyr1-derived compositions and methods of treatment using same
BR112013022530A2 (en) homeopathic therapeutic method and compositions
EP2709466A4 (en) Method of treating honey
HK1202819A1 (en) Treatment of type i and type ii diabetes i ii
EP2731679A4 (en) Uv protective skin treatment compositions and screening methods
GB201113140D0 (en) Prediction and treatment of cancer
IL237490B (en) System and method for treatment of water
HUP1100288A2 (en) Arrangement artificial uv light from setting of uvb and uva rate
GB201204163D0 (en) Light unit and method of illumination
AU2011900870A0 (en) Disinfection and filtration of water
EP2685820A4 (en) Compositions and methods for treatment of infections
GB201119184D0 (en) Light treatment method
GB201119181D0 (en) Light treatment method
GB201118869D0 (en) Light treatment method
GB201100651D0 (en) Treatment of inflammation